Current antimicrobial therapy of anaerobic infections (Q35212734)

7 August 2017

1 reference

title

Current antimicrobial therapy of anaerobic infections (English)

1 reference

7 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1295770

10 September 2022

author name string

C. V. Sanders

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1295770

10 September 2022

K. E. Aldridge

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1295770

10 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1295770

10 September 2022

publication date

1 November 1992

1 reference

full work available at URL

7 August 2017

http://link.springer.com/content/pdf/10.1007/BF01967790.pdf

1 reference

http://link.springer.com/article/10.1007/BF01967790/fulltext.html

28 November 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF01967790

28 November 2023

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

28 November 2023

published in

1 reference

7 August 2017

volume

11

1 reference

7 August 2017

issue

11

1 reference

7 August 2017

page(s)

999-1011

1 reference

Clindamycin compared with penicillin for the treatment of anaerobic lung abscess

7 August 2017

cites work

1 reference

Susceptibility of anaerobic bacteria to 23 antimicrobial agents

21 January 2018

1 reference

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group

21 January 2018

1 reference

Chloramphenicol Acetyltransferase of Bacteroides fragilis

21 January 2018

1 reference

Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement

21 January 2018

1 reference

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis

21 January 2018

1 reference

Biochemical properties and purification of metallo-beta-lactamase from Bacteroides fragilis

21 January 2018

1 reference

Characterization of three different beta-lactamases from the Bacteroides fragilis group

21 January 2018

1 reference

Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections

21 January 2018

1 reference

Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species

21 January 2018

1 reference

Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology

21 January 2018

1 reference

Prospective, randomized comparative study of clindamycin, chloramphenicol, and ticarcillin, each in combination with gentamicin, in therapy for intraabdominal and female genital tract sepsis

21 January 2018

1 reference

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates

21 January 2018

1 reference

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

21 January 2018

1 reference

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate

21 January 2018

1 reference

Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria

21 January 2018

1 reference

In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor

21 January 2018

1 reference

Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections

21 January 2018

1 reference

In vitro activities of three of the newer quinolones against anaerobic bacteria

21 January 2018

1 reference

Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria

21 January 2018

1 reference

Cefmetazole sodium (Zefazone)

21 January 2018

1 reference

12 December 2020

Cefotetan: summary of the symposium from an internist's viewpoint

1 reference

12 December 2020

Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections

1 reference

12 December 2020

In vitro comparison of cefoperazone/sulbactam with selected antimicrobials against 300 bacteroides isolates. Inhibitory activity and time-kill kinetic studies.

1 reference

12 December 2020

Antimicrobial resistance in Bacteroides

1 reference

12 December 2020

In vitro activity of selected antibiotics against anaerobes

1 reference

12 December 2020

Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections

1 reference

12 December 2020

Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin

1 reference

12 December 2020

Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology

1 reference

12 December 2020

Cefotetan and hypoprothrombinemia

1 reference

12 December 2020

Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin

1 reference

12 December 2020

Imipenem therapy for perforated and gangrenous appendicitis.

1 reference

12 December 2020

Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid

1 reference

12 December 2020

In-vitro studies of meropenem

1 reference

12 December 2020

A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections

1 reference

12 December 2020

Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus.

1 reference

12 December 2020

Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections

1 reference

12 December 2020

Mechanisms of beta-lactam resistance in anaerobic bacteria.

1 reference

12 December 2020

Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy.

1 reference

12 December 2020

In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.

1 reference

12 December 2020

Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.

1 reference

12 December 2020

Antibacterial activity of imipenem: the first thienamycin antibiotic

1 reference

12 December 2020

Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens

1 reference

12 December 2020

In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates

1 reference

12 December 2020

Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin /- dicloxacillin

1 reference

12 December 2020

Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy.

1 reference

12 December 2020

Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections

1 reference

12 December 2020

Transferable 5-nitroimidazole resistance in the Bacteroides fragilis group

1 reference

12 December 2020

Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates

1 reference

12 December 2020

Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone

1 reference

12 December 2020

A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.

1 reference

12 December 2020

Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.

1 reference

12 December 2020

A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis

1 reference

12 December 2020

Bacteroides fragilis resistant to both metronidazole and imipenem.

1 reference

12 December 2020

Cefmetazole postmarketing surveillance in Japan

1 reference

12 December 2020

Cefotetan: a perspective for the surgical patient

1 reference

12 December 2020

Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infections.

1 reference

12 December 2020

Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin

1 reference

12 December 2020

Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.

1 reference

12 December 2020

A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections

1 reference

12 December 2020

Prospective, randomized comparison of metronidazole and clindamycin, each with gentamicin, for the treatment of serious intra-abdominal infection

1 reference

12 December 2020

Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-solbactam and other antimicrobial agents

1 reference

12 December 2020

Inactivation of metronidazole by Enterococcus faecalis

1 reference

12 December 2020

Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility

1 reference

12 December 2020

Mechanisms of resistance in anaerobes and new developments in testing

1 reference

12 December 2020

The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.

1 reference

12 December 2020

Metronidazole in the treatment of anaerobic infections

1 reference

12 December 2020

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections

1 reference

12 December 2020

Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains

1 reference

12 December 2020

Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: A multicenter study

1 reference

12 December 2020

1

3

332

SM Finegold

1984

1 reference

American Review of Respiratory Disease

28 November 2023

17

120

337

CV Sanders

1979

1 reference

Diagnostic Microbiology and Infectious Disease

28 November 2023

39

2

47

KE Aldridge

1984

1 reference

28 November 2023

43

7

64

DN Gerding

1988

1 reference

28 November 2023

44

7

57

MA Lou

1988

1 reference

28 November 2023

46

7

51

JS Solomkin

1988

1 reference

28 November 2023

Identifiers

DOI

10.1007/BF01967790

1 reference

7 August 2017

1 reference